Recent reports elucidated that B7-H3 (B7 homolog 3 protein, also known as CD276) controlled cancer progression and prolonged the survival of patients via targeted chimeric antigen receptor (CAR)-T cells and CAR-NK cells [42, 43]. This evidence concerns the gene CD276 and cancer.